![]() |
|
|
|
»Home
»What is Vioxx »About Vioxx »Side Effects »Vioxx Recall »Vioxx Lawyers »Vioxx News FDA Vioxx Info
|
Welcome to Vioxx LawsuitsWe provide news and legal information about the Vioxx litigation, Vioxx class action and FDA announcements. Vioxx RecallOn September 30, 2004, Merck & Co., Inc. announced a voluntary withdrawal of Vioxx from the U.S. market due to safety concerns. Vioxx has been linked to serious cardiovascular events, including heart attacks and strokes. Vioxx is a prescription COX-2 selective, non-steroidal anti-inflammatory drug (NSAID) that was approved by FDA in May 1999 for the relief of the signs and symptoms of osteoarthritis, for the management of acute pain in adults, and for the treatment of menstrual symptoms. It is also approved for the relief of the signs and symptoms of rheumatoid arthritis in adults and children. Vioxx Lawyers |
Vioxx Legal News »
Vioxx on 60 Minutes |
||||
|
© 2004-2005 Vioxx Lawsuits | Advertise | Resources |
Contact: info@vioxxlawsuits.info |
|
Disclaimer: The information contained in this website does not constitute legal advice. We make no promises, claims or guarantees about the completeness, accuracy, or adequacy of the information contained in or linked to this web site and websites it we link to. Legal advice is specific to each case, current laws and must be addressed by an experienced lawyer. Trademark Notice: "Vioxx" is a registered trademark of Merck. VioxxLawsuits.info is in no way affiliated with Merck, and the Vioxx trademark is used solely for informational purposes. |
|